Synairgen PLC (SNG)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

4.32p

Buy

4.92p

arrow-up0.00p (+0.00%)

Prices updated at 19 Nov 2024, 15:16 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
Synairgen PLC is a respiratory drug discovery and development company. It is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, chronic obstructive pulmonary disease.
FTSE All-Share
arrow-down-0.09%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
4.49p - 4.26p
11.00p - 3.00p
-
7.05m
-
75,000
14,725
0.98
358,851.06
1.76
201.37m
GB00B0381Z20
-0.03
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.